TotalMarketCap

Nasus Pharma

NSRXNYSE IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$33.786 M

$2.89 -1.20%

Close of 6 Nov 2026

As of 6 Nov 2026, Nasus Pharma (NSRX) has a market capitalization of $33.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.24B

#1395 by revenue

Earnings

-$5.86M

Loss-making

Shares outstanding

9,015,383

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #356VeruVERU$35.0M
  2. #357GridAI TechnologiesGRDX$33.9M
  3. #358Nasus PharmaNSRX$33.8M
  4. #359ScynexisSCYX$33.1M
  5. #360NanoviricidesNNVC$32.9M

What if Nasus Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,411,181

Per share 835,765× higher

Bitcoin $1.53T

$130,464.79

Per share 45,222× higher

Apple $5.02T

$428,303.72

Per share 148,459× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Nasus Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.